Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage

Table 2

Anticancer treatment-related complications, classified according to GAP stage.

	Total (n=53)	GAP stage I (n=39)	GAP stage II/III (n=14)	p value
AE-IPF	16 (30.2)	8 (20.5)	8 (57.1)	0.017
Pneumonia	18 (34.0)	10 (25.6)	8 (57.1)	0.049
Cytopenia	32 (60.4)	23 (59.0)	9 (64.3)	0.727
GI trouble	18 (34.0)	11 (28.2)	7 (50.0)	0.191
PTE	5 (9.4)	2 (5.1)	3 (21.4)	0.108

Values are presented as No. (%).
Abbreviations: AE-IPF, acute exacerbation of idiopathic pulmonary fibrosis; GAP, gender, age, and physiology; GI, gastrointestinal; PTE, pulmonary thromboembolism.